Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease

胶囊 体内 胃 医学 胃肠道 信使核糖核酸 口服 小肠 药理学 化学 生物 内科学 基因 生物化学 植物 生物技术
作者
Xiangang Huang,Chuang LIU,Shonit Nair Sharma,Xinru You,Shuying Chen,Yongjiang Li,H.-J. Liu,Bin Liu,Qimanguli Saiding,Wei Chen,Yuhan Lee,Na Kong,Reza Abdi,Wei Tao
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:17 (807): eadu1493-eadu1493 被引量:44
标识
DOI:10.1126/scitranslmed.adu1493
摘要

Oral delivery of messenger RNA (mRNA) therapeutics could offer noninvasive and self-administered treatments and vaccinations. However, the development of oral mRNA therapeutics remains challenging because of the degradative conditions of the gastrointestinal (GI) tract. Here, we engineered a capsule-based device, named RNACap, designed for oral delivery of liquid mRNA nanoparticle (NP) therapeutics to the intestines. RNACap protects mRNA from the acidic stomach environment while allowing rapid release into the intestines in response to intestinal neutral pH, pressure release due to the dissolution of capsule cap, and natural intestinal contractions (peristalsis). This process enables NP-mediated delivery of mRNA into intestinal cells for in vivo transfection. We optimized an NP formulation for rapid intestinal mRNA delivery. In rat and porcine models, we confirmed that the RNACap remains intact in the stomach but releases its contents within the intestines. The release of mRNA NPs led to the expression of multiple mRNAs. The therapeutic effect of the RNACap was demonstrated by acute and delayed treatment in two rat colitis models. Orally administered RNACaps loaded with mRNA encoding interleukin-10 ( IL-10 mRNA NP) reduced proinflammatory cytokine concentrations in both blood and tissues, ultimately alleviating colitis. Furthermore, using a large-animal model of swine, we showed that RNACaps remained intact in the stomach, disassembled in the intestine, and resulted in robust mRNA expression just 8.5 hours after administration. RNACap represents a promising platform for the oral delivery of liquid mRNA therapeutics to the GI tract for treating challenging intestinal diseases and potentially other conditions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
房子完成签到,获得积分10
刚刚
刚刚
乐乐的应助被sfliufighting采纳,获得10
1秒前
领导范儿的应助被冷冷子采纳,获得80
1秒前
香蕉觅云的应助被EstAffectus采纳,获得30
2秒前
CodeCraft的应助被EstAffectus采纳,获得30
2秒前
李健的应助被EstAffectus采纳,获得10
2秒前
2秒前
桐桐的应助被EstAffectus采纳,获得10
2秒前
NexusExplorer的应助被EstAffectus采纳,获得30
2秒前
搜集达人的应助被EstAffectus采纳,获得10
3秒前
李健的应助被EstAffectus采纳,获得10
3秒前
李爱国的应助被EstAffectus采纳,获得30
3秒前
3秒前
所所的应助被EstAffectus采纳,获得10
3秒前
烟花的应助被EstAffectus采纳,获得10
3秒前
房子发布了新的文献求助10
3秒前
hc发布了新的文献求助10
4秒前
鸽子二号完成签到,获得积分10
4秒前
二二春完成签到,获得积分10
5秒前
深情安青的应助被友好的诗筠采纳,获得10
6秒前
椰椰完成签到,获得积分10
6秒前
6秒前
nami发布了新的文献求助10
6秒前
6秒前
彩色樱桃发布了新的文献求助10
6秒前
大晴子发布了新的文献求助10
7秒前
8秒前
zombie发布了新的文献求助10
9秒前
Maestro_S的应助被EstAffectus采纳,获得150
9秒前
NexusExplorer的应助被EstAffectus采纳,获得10
9秒前
爆米花的应助被EstAffectus采纳,获得30
9秒前
困了发布了新的文献求助10
9秒前
orixero的应助被EstAffectus采纳,获得10
9秒前
高乾完成签到 ,获得积分10
9秒前
紫呀完成签到 ,获得积分10
9秒前
田様的应助被EstAffectus采纳,获得30
9秒前
9秒前
10秒前
可爱的函函的应助被沉默采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573478
关于积分的说明 21831914
捐赠科研通 7781737
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962